Information Provided By:
Fly News Breaks for April 25, 2018
EW
Apr 25, 2018 | 08:47 EDT
Canaccord analyst Jason Mills said he likes the trends coming out of the Edwards Lifesciences Q1 results and he recommended investors buy the shares on any weakness. He noted the company was going up against the toughest comps of the year along with heightened expectations coming off the Q4 TAVR performance. Mills reiterated his Buy rating and $174 price target on Edwards Lifesciences shares.
News For EW From the Last 2 Days
There are no results for your query EW
I agree to the thefly.com's disclaimer & terms of use
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.